![Andreas Schmiede](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Schmiede
Corporate Officer/Principal presso
MEDIOS AG
Profilo
Andreas Schmiede is currently Vice President-Advanced Therapies at Medios AG since 2024.
Formerly, Dr. Schmiede was Head-Business Development Cell & Gene Therapy at Lonza Cologne GmbH.
Posizioni attive di Andreas Schmiede
| Società | Posizione | Inizio |
|---|---|---|
| MEDIOS AG | Corporate Officer/Principal | 05/08/2024 |
Precedenti posizioni note di Andreas Schmiede
| Società | Posizione | Fine |
|---|---|---|
Lonza Cologne GmbH
 Lonza Cologne GmbH BiotechnologyHealth Technology Provides biotechnological research and development services | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
5
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Medios AG
 Medios AG Medical DistributorsDistribution Services Engages in trading specialty pharmaceutical drugs | Distribution Services |
Lonza Cologne GmbH
Lonza Cologne GmbH BiotechnologyHealth Technology Provides biotechnological research and development services | Health Technology |
